Posts for Ticker ‘ARAY’

Top Day Trader Alerts (ARAY, COCO, GME, HGSI, NVAX, BCRX, SIRI)

These are this Tuesday’s top day trader and active trader alerts with more detailed price and volume data and analysis provided by links to each story at VSInvestor.com:

Accuray Incorporated (NASDAQ: ARAY) is down but not as active on the heels of active trading last night.  We saw a drop of 10% still being in the stock….

Corinthian Colleges, Inc. (NASDAQ: COCO) did beat earnings and raise guidance, sending shares up 12% and still under the 52-week highs.  Watch APOL and CECO on the news….

GameStop Corp. (NYSE: GME) is indicated marginally lower after losing its CFO.

Human Genome Sciences, Inc. (NASDAQ: HGSI) was up the most of the active biotechs up over 7% on yesterday’s deal hopes and today’s swine flu hopes.

Novavax Inc. (NASDAQ: NVAX) and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) are both actively traded and higher this morning because of the swine flu boost.

SIRIUS XM Radio Inc. (NASDAQ: SIRI) is looking a little tired, but this would be a 6th day gain if it can stay strong again.

-The 24/7 Wall Street Team

Posted on: August 25, 2009 – 9:13 am in Pre-Market Activity, Trading Alert, , , , , , ,

Top Pre-Market Analyst Upgrades (ARAY, AZN, SAM, BSX, CNX, MLM, TER, TWX)

These are some of the top pre-market analyst upgrades and positive calls we have seen on Wall Street this Friday morning:

  • Accuray (ARAY) Raised to Buy at Piper Jaffray.
  • AstraZeneca (AZN) Raised to Buy at Deutsche Bank.
  • Boston Beer (SAM) Raised to Neutral from Sell at Goldman Sachs.
  • Boston Scientific (BSX) Raised to Outperform at Wachovia.
  • CONSOL Energy (CNX) Raised to Buy at Citigroup.
  • Martin Marietta (MLM) Raised to Neutral at UBS.
  • Teradyne (TER) Raised to Buy at Goldman Sachs.
  • Time Warner (TWX) Started as Buy at Collins Stewart.

Jon C. Ogg
January 30, 2009

Posted on: January 30, 2009 – 7:55 am in Analyst Calls, , , , , , , ,

The 52-Week Low Club (CDNS)(ARAY)(RNOW)(CRUS)(HSTX)

Cadence Design Systems (CDNS) posts bad numbers and gets downgrades. Falls to $9.90 from 52-week high of $24.90.

Accuray (ARAY) The radiosurgery device maker reported disappointing fiscal second-quarter results. Trades off to $9.26 from 52-week high of $31.90.

Rightnow Technologies (RNOW) Poor financial outlook. Drops to $9.70 from 52-week high $23.38.

Cirrus Logic (CRUS) Market unhappy with profits. Falls to $4 from 52-week high of $9.44.

Harris Stratex Networks (HSTX) Weak results hit stock. Falls to $10.11 from 52-week high of $21.25.

Douglas A. McIntyre

Posted on: January 31, 2008 – 4:00 pm in HI/LOW, , , , ,

Accuray, Neither Recession Proof Nor Credit Proof (ARAY)

Accuray Inc. (NASDAQ: ARAY) is being punished in after-hours trading.  The company posted earnings at $0.04 EPS on revenues of $52 million.  The problem is that First Call was at $0.09 EPS on $58.2 million. The company also gave 2008 revenue guidance of $210 to $230 million, down from a prior guidance of $250 to $270 million and down from consensus estimates of almost $265 million.  This represents 50% to 64% revenue growth projected over 2007, but it isn’t enough.

Accuray was in a position that you would think is recession-proof and full of growth ahead.  Its own CyberKnife Robotic Radiosurgery System treats tumors anywhere in the body non-invasively with continual image guidance technology and computer controlled robotic mobility.  As it monitors movement real-time, it delivers targeted high-dose radiation to minimize damage to surrounding healthy tissue.  It also eliminates the need for invasive head or body stabilization frames.  Shouldn’t that be recession proof????

You have to see the comments here and determine if you believe the CEO, Euan S. Thomson, Ph.D.:  "Accuray continues to experience record-setting growth…. This sustained growth is a testament to the impact that the CyberKnife System is having on meeting the demands for extracranial radiosurgery, particularly prostate and lung cancer…. While this was a positive quarter with respect to revenue and backlog growth, we believe that broader credit market issues are having a short-term impact on some of our U.S. customers’ purchase and installation timelines, as obtaining financing has become more difficult…."

Shares closed down 1% today at $14.98 and the 52-week trading range was $12.50 to $31.09.  But after-hours is ugly and a new 52-week low down almost 30% to under $11.00. 
You might wonder if Accuray’s salesforce has trouble pitching gold for the price of silver.  Something just doesn’t seem right here.

Jon C. Ogg
January 30, 2008 

Posted on: January 30, 2008 – 5:35 pm in Earnings, Earnings Warning, Medical, ,

The 52-Week Low Club

Accuray (ARAY) Radiosurgery company has quarterly loss. Down to $12.90 from 52-week high of $31.09.

Home Solutions (HSOA) Problems with credit facility. Down to $2.85 from 52-week high of $8.24.

Tarragon (TARR) Apartment and condominium builder says it may have to close. Stock falls to $.52 from 52-week high of $13.50.

Douglas A. McIntyre

Posted on: August 17, 2007 – 3:09 pm in HI/LOW, , ,